TopFunds

Ventas

NYSE: VTR

Stock price

85.63 USD

(+0%) TODAY

Health Care REITsREIT - Healthcare Facilities
Financials

all figures in US$ Millions except per share data

Sections:

Periods:

View:

Format:

Actual
10 year cagr
Help
Where available up to 10y CAGR shown for absolute numbers 10y Average marked A shown for relative numbers such as margins
Fiscal
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Average (A)
Fiscal period end dates
Expand all rows
01Earnings per share
Help
Earnings per share = Net Income / Number of Shares Outstanding
1.3
1.9
3.8
1.1
1.2
1.2
0.1
(0.1)
(0.1)
0.2
0.5
(8.1)%
02Free cash flow per share
3.8
3.6
3.6
3.6
3.5
3.5
2.2
2.5
2.3
2.5
2.8
(3)%
03Dividends per share
3.3
3
3.1
3.2
3.2
2.1
1.8
1.8
1.8
1.8
1.9
(5.2)%
04Dividends payout, %
2.4%
1.6%
61%
2.8%
2.7%
2.1%
14%
(15.2)%
(17.7)%
9.1%
3.4%
3.6%
PROFIT AND LOSS STATEMENT
05Revenue
$ 3,286
$ 3,444
$ 3,574
$ 3,746
$ 3,873
$ 3,795
$ 3,828
$ 4,129
$ 4,498
$ 4,924
$ 5,834
5.9%
06% Change
-
4.8%
3.8%
4.8%
3.4%
(2)%
0.9%
7.9%
8.9%
9.5%
18.5%
5.9%
07Cost of revenue
(1,410)
(1,442)
(1,487)
(1,691)
(1,811)
(1,940)
(2,089)
(2,283)
(2,561)
(2,827)
(6,178)
15.9%
08Gross profit
1,876
2,001
2,088
2,055
2,062
1,856
1,740
1,846
1,937
2,097
(344.2)
-
09% Margin
57.1%
58.1%
58.4%
54.9%
53.3%
48.9%
45.4%
44.7%
43.1%
42.6%
(5.9)%
45.5% A
10Operating expenses
(1,022)
(1,026)
(1,023)
(1,072)
(1,204)
(1,264)
(1,318)
(1,362)
(1,521)
(1,416)
(1,171)
-
11% of Revenue
(31.1)%
(29.8)%
(28.6)%
(28.6)%
(31.1)%
(33.3)%
(34.4)%
(33)%
(33.8)%
(28.8)%
(20.1)%
(26.6)% A
12Operating Income
834.7
556.8
622.1
861.1
857.9
591.4
421.4
483.8
415.5
681.2
826.8
(0.1)%
13Income tax expense
(39.3)
(31.3)
(59.8)
(40)
(56.3)
(96.5)
(4.8)
(16.9)
(9.5)
(37.8)
(14.1)
(9.7)%
14Net Income
417.8
649.2
1,357
409.5
433
439.1
49
(47.4)
(41)
81.2
251.4
(5)%
15% Margin
12.7%
18.9%
38%
10.9%
11.2%
11.6%
1.3%
(1.2)%
(0.9)%
1.7%
4.3%
9.9% A
16Shares Outstanding
334,007
348,390
358,566
359,301
369,886
376,503
386,304
373,368
405,670
416,366
462,615
3.3%
17EPS Basic
1.3
1.9
3.8
1.2
1.2
1.2
0.1
(0.1)
(0.1)
0.2
0.6
(8)%
18EPS Diluted
1.3
1.9
3.8
1.1
1.2
1.2
0.1
(0.1)
(0.1)
0.2
0.5
(8.1)%
19EBITDA
1,611
1,905
2,605
1,709
1,747
1,770
1,480
1,500
1,700
1,821
2,239
3.3%
% Margin
49%
55.3%
72.9%
45.6%
45.1%
46.6%
38.7%
36.3%
37.8%
37%
38.4%
45.7% A
20Net Interest Income (expense)
(367.1)
(419.7)
(448.2)
(442.5)
(451.7)
(469.5)
(440.1)
(467.6)
(574.1)
(602.8)
(589.7)
4.9%
21Net Debt / EBITDA
6.9
5.7
4.3
6.2
7
6.6
8.2
8.2
7.8
7.1
5.6
6.7 A
BALANCE SHEET
ASSETS
Current Assets
22Cash & equivalents
53
286.7
81.4
72.3
106.4
413.3
149.7
122.6
508.8
897.9
741.1
30.2%
23Short-term investments
63.7
55
54.7
206.4
237.4
237.6
-
-
-
-
-
-
24Accounts receivable
1,050
944.1
1,619
800.1
1,047
832.4
726
748.9
248.2
375.7
415.6
(8.9)%
25Other current assets
171
135.6
172.3
64.6
125.3
47.9
75.3
93.1
111.2
78
169.5
(0.1)%
26Inventory
-
-
-
-
-
-
-
-
-
-
-
-
27Total Current Assets
1,338
1,422
1,928
1,143
1,516
1,531
951
964.6
868.2
1,352
1,326
(0.1)%
Non-Current Assets
28Net property, plant & equipment
-
-
-
-
-
-
-
-
-
-
-
-
29Long-term investments
123.9
124.4
173.4
105.2
104.3
507.5
597.1
675.3
678.5
721.7
718.2
19.2%
30Other non-current assets
20,800
21,621
21,854
21,336
23,072
21,891
23,170
22,518
23,179
24,114
25,548
2.1%
31Total Non-Current Assets
20,924
21,745
22,027
21,441
23,176
22,398
23,767
23,193
23,857
24,835
26,266
2.3%
Total Assets
22,262
23,167
23,955
22,585
24,692
23,929
24,718
24,158
24,725
26,187
27,592
2.2%
LIABILITIES
Current Liabilities
32Accounts payable
779.4
907.9
1,184
1,086
1,146
1,133
1,090
1,032
1,042
1,152
1,241
4.8%
33Short-term debt
180.7
146.5
538.7
856.4
848.7
193.5
336.4
428.2
14
6.4
-
-
34Other current liabilities
115.2
85.2
154.2
99.9
116.3
114.7
117.5
117
126.6
146.1
147.1
2.5%
35Total Current Liabilities
1,075
1,140
1,876
2,042
2,111
1,441
1,544
1,577
1,182
1,305
1,388
2.6%
Non-Current Liabilities
36Long-term debt
11,026
10,981
10,737
9,877
11,561
11,912
11,888
12,059
13,672
13,734
13,220
1.8%
37Other non-current liabilities
534.9
517.4
408.6
393.4
474.5
298.1
339.5
300.2
327.1
318.4
398.6
(2.9)%
38Total Non-Current Liabilities
11,561
11,498
11,146
10,271
12,036
12,210
12,228
12,359
13,999
14,053
13,618
1.7%
39Total Liabilities
12,637
12,638
13,022
12,313
14,147
13,651
13,772
13,936
15,181
15,357
15,006
1.7%
SHAREHOLDERS` EQUITY
40Common stock
83.6
88.5
89
89.1
93.2
93.6
99.8
99.9
100.6
109.1
118.7
3.6%
41Retained earnings / (deficit)
(2,112)
(2,488)
(2,241)
(2,930)
(3,669)
(4,030)
(4,680)
(5,449)
-
-
-
-
42Accumulated other comprehensive income / (loss)
(2,120)
(2,545)
(2,276)
(2,950)
(3,704)
(4,085)
(4,744)
(5,486)
(6,250)
(6,920)
(7,568)
13.6%
43Noncontrolling interests
61.1
68.5
66
55.7
99.6
98
91.4
68.7
56.3
58.3
58.6
(0.4)%
44Total shareholders' equity
9,625
10,529
10,932
10,272
10,546
10,278
10,946
10,222
9,544
10,830
12,586
2.7%
45Total Liabilities and shareholders' Equity
22,262
23,167
23,955
22,585
24,692
23,929
24,718
24,158
24,725
26,187
27,592
2.2%
46Total Debt
11,207
11,127
11,276
10,734
12,410
12,105
12,225
12,487
13,686
13,741
13,220
1.7%
47Net Debt
11,154
10,841
11,195
10,661
12,304
11,692
12,075
12,365
13,177
12,843
12,479
1.1%
CASH FLOW STATEMENT
CASH FLOWS FROM OPERATING ACTIVITIES
48Net income (loss)
417.8
649.2
1,357
409.5
433
439.1
49
(47.4)
(41)
81.2
251.4
(5)%
49Depreciation & amortization
894.1
863.7
855
890.1
912
956
978
1,090
1,166
1,167
1,379
4.4%
50Share-based compensation expense
-
-
-
-
-
-
-
-
-
-
-
-
51Changes in working capital and other assets
79.9
(145.5)
(776.6)
139.3
92.9
55.1
17
105.9
69.7
89.7
49.9
(4.6)%
52Net cash flows from operating activities
1,392
1,368
1,435
1,439
1,438
1,450
1,044
1,149
1,195
1,338
1,680
1.9%
CASH FLOWS FROM INVESTING ACTIVITIES
53Purchases of property, plant and equipment
(107.5)
(117.5)
(132.6)
(131.9)
(156.7)
(148.2)
(185.3)
(222.1)
(259.4)
(281.6)
(363.9)
13%
54Purchases of investments / marketable securities
(5,448)
(1,731)
(1,773)
(873.3)
(2,624)
(861)
(1,747)
(792.9)
(523.3)
(2,443)
(2,631)
(7)%
55Proceeds from maturities of marketable securities
601.6
620.6
961
1,265
1,165
1,163
1,189
113.8
494.2
336
262
(8)%
56Other investing activities
(3.8)
(2)
(10)
4.1
36.5
(6.7)
(21.2)
18.9
49.3
(3.8)
3
-
57Net cash flows from investing activities
(4,957)
(1,230)
(954.7)
264.2
(1,579)
147.4
(764.5)
(882.3)
(239.2)
(2,393)
(2,730)
(5.8)%
CASH FLOWS FROM FINANCING ACTIVITIES
58Issuance (repurchases) of common stock, net
491
1,287
73.6
(1.4)
976.1
69.9
625.5
7.2
109.1
1,989
2,452
17.5%
59Dividends paid, net
(1,003)
(1,025)
(827.3)
(1,127)
(1,158)
(928.8)
(686.9)
(720.3)
(723.6)
(740.3)
(860.1)
(1.5)%
60Debt issuance (repayments), net
1,600
(171.1)
100.1
(615.3)
363.5
(409)
(448)
468.8
97.7
249.1
(670.5)
-
61Other financing activities
(53.9)
6.6
(6.3)
(15.3)
(27.5)
(25.2)
(26.6)
(44.8)
(47.1)
(44.7)
(45.9)
(1.6)%
62Net cash flows from financing activities
1,034
97.2
(659.9)
(1,759)
154.4
(1,293)
(536)
(289.1)
(563.9)
1,453
875.7
(1.7)%
63Increase (decrease) in cash and cash equivalents
(2.3)
233.7
(205.4)
(56.8)
14.6
305.5
(255)
(25.9)
392.7
393.8
(171.1)
53.7%
64Cash and equivalents, ending balance
53
286.7
81.4
131.5
146.1
451.6
196.6
170.7
563.5
957.2
786.1
31%
65Free Cash Flow to the Firm (FCFF)
Help
Free Cash Flow to the Firm = Cash Flows from Operating Activities - Capital Expenditures
1,284
1,250
1,302
1,307
1,281
1,302
858.7
926.3
935.1
1,056
1,317
0.3%

Annual Reports, Presentations And IR Contacts

Go to the website
Annual report links (10K)
2025202420232022202120202019201820172016

Ventas (VTR) financial statements and performance

Explore Ventas (VTR) annual and quarterly financial statements, including revenue, operating income, net income, cash flow, assets, liabilities, and per-share metrics.

Compare reporting periods and financial trends to evaluate profitability, balance-sheet strength, cash generation, and long-term business performance.